Serum N‐Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism
Main Authors: | Keyte, S.V., Kenny, P.J., Forcada, Y., Church, D.B., Niessen, S.J.M. |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108467/ |
Similar Items
-
Pasireotide for the Medical Management of Feline Hypersomatotropism
by: Scudder, C.J., et al.
Published: (2015) -
Evaluation and Diagnostic Potential of Serum Ghrelin in Feline Hypersomatotropism and Diabetes Mellitus
by: Jensen, K.B., et al.
Published: (2015) -
Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus
by: Fletcher, J.M., et al.
Published: (2016) -
Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults
by: Fragala, Maren S., et al.
Published: (2013) -
Procollagen C-proteinase Enhancer Stimulates Procollagen Processing by Binding to the C-propeptide Region Only*
by: Vadon-Le Goff, Sandrine, et al.
Published: (2011)